<--- Back to Details
First PageDocument Content
Health / European Medicines Agency / Summary of Product Characteristics / MedDRA / Adverse drug reaction / Adverse effect / Pseudoephedrine / Pharmacovigilance / Pharmacology / Pharmaceutical sciences / Medicine
Date: 2015-07-02 05:24:35
Health
European Medicines Agency
Summary of Product Characteristics
MedDRA
Adverse drug reaction
Adverse effect
Pseudoephedrine
Pharmacovigilance
Pharmacology
Pharmaceutical sciences
Medicine

Text of introduction - January 2013

Add to Reading List

Source URL: www.imi-protect.eu

Download Document from Source Website

File Size: 70,33 KB

Share Document on Facebook

Similar Documents

The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections EMEA/CVMPFINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

DocID: 1vrLd - View Document

7 May 2018 EMAHuman Medicines Research and Development Support Division European Medicines Agency Guidance for applicants seeking access to PRIME scheme

DocID: 1vlIp - View Document

The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 23 January 2003 CPMP/SWP

DocID: 1ucvu - View Document

2 March 2016 EMAExternal guidance on the implementation of the European Medicines Agency policy on the publication of clinical data for medicinal products for human use

DocID: 1sVev - View Document

European Medicines Agency: Celebrating 20 years

DocID: 1sUY9 - View Document